Company Filing History:
Years Active: 2000
Title: Edward M Rockenstein: Innovator in Translational Start Sites
Introduction
Edward M Rockenstein is a notable inventor based in Chula Vista, California. He has made significant contributions to the field of biotechnology, particularly in the area of translational start sites.
Latest Patents
Rockenstein holds a patent for a non-optimal Kozak sequence. This patent describes a non-optimal translational start site polynucleotide sequence, as set forth in SEQ ID NO:2. The invention also includes an expression vector for expressing a protein of interest, utilizing the non-optimal translational start site. Additionally, it provides host cells containing the expression vector and a selectable marker encoded by nucleic acid sequences that utilize the non-optimal translational start site. He has 1 patent to his name.
Career Highlights
Edward M Rockenstein is associated with Aurora Biosciences Corporation, where he has been instrumental in advancing research and development in his field. His work has contributed to the understanding and application of translational start sites in biotechnology.
Collaborations
Rockenstein has collaborated with Michael A Whitney, further enhancing the innovative efforts within their research team.
Conclusion
Edward M Rockenstein's contributions to biotechnology, particularly through his patent on non-optimal Kozak sequences, highlight his role as an innovator in the field. His work continues to influence advancements in protein expression and genetic research.